Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127695581 | 12769558 | 1 | I | 20160915 | 20160915 | 20160922 | 20160922 | PER | US-ASTRAZENECA-2016SF00382 | ASTRAZENECA | 15887.00 | DY | F | Y | 123.80000 | KG | 20160922 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127695581 | 12769558 | 1 | PS | BYETTA | EXENATIDE | 1 | Unknown | 51140 | MG | U | U | UNKNOWN | 21773 | 10 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | ||
| 127695581 | 12769558 | 2 | C | DIOVAN | VALSARTAN | 1 | Oral | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127695581 | 12769558 | 1 | Type 2 diabetes mellitus |
| 127695581 | 12769558 | 2 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127695581 | 12769558 | Injection site haemorrhage | |
| 127695581 | 12769558 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127695581 | 12769558 | 1 | 2009 | 0 | ||
| 127695581 | 12769558 | 2 | 2007 | 0 |